Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank83
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-2.95
↑ 93% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-45.28
Historical baseline
PeriodValueYoY Change
TTM-2.95-64.8%
2025-1.79+55.9%
2024-4.06+14.0%
2023-4.72+24.2%
2022-6.23+10.5%
2021-6.96+48.3%
2020-13.47+66.0%
2019-39.60+53.4%
2018-85.00+70.5%
2017-288.00-